# Pharmacogenomics Study on Treatment of Psoriasis Vulgaris by Methotrexate

> **NCT02715947** · PHASE2 · UNKNOWN · sponsor: **Central South University** · enrollment: 400 (estimated)

## Conditions studied

- Psoriasis Vulgaris

## Interventions

- **DRUG:** Methotrexate

## Key facts

- **NCT ID:** NCT02715947
- **Lead sponsor:** Central South University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-12
- **Primary completion:** 2017-12
- **Final completion:** 2017-12
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2016-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02715947

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02715947, "Pharmacogenomics Study on Treatment of Psoriasis Vulgaris by Methotrexate". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02715947. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*